The clinical relevance of fetal nuchal translucency;Die klinische bedeutung der fetalen nackentranparenz

Gynakologe

Volumn 32, Issue 3, 1999, Pages 200-212

  Baz E ^a   Hecher, K ^a   Hackeloer B J ^a  

^a NONE

Author keywords

Chromosomal Abnormality; Fetal anomalies; Fetal structural anomalies; Fetal ultrasound; First trimester screening; High risk groups; Nuchal translucency; Risk estimation

Indexed keywords

ARTICLE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FETUS ECHOGRAPHY; FETUS HYDROPS; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; IMAGE ANALYSIS; NECK; CHROMOSOME ABERRATION; FALSE POSITIVE RESULT; FETUS DISEASE; GENETIC DISORDER; HIGH RISK PREGNANCY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY DISORDER; TREATMENT PLANNING; TWIN TWIN TRANSFUSION SYNDROME;

EID: 85047680532     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00003220     Document Type: Article

References (80)

1. Snijders RJM, Noble P, Sebire NJ, Souka AP, Nicolaides KH (1998) UK multicentre project on assessment of risk for trisomy 21 by maternal age and fetal translucency at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352: 343-346
2. Macintosh MCM, Wald NJ, Chard T et al. (1995) Selective miscarriage of Down's syndrome in women aged 35 years and older. Br J Obstet Gynecol 102: 798-801
3. Nicolaides KH, Snijders RJ, Gosden CM, Berry C, Campbell S (1992) Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 340: 704-707
4. Wald NJ, Cuckle HS, Densem JW et al. (1988) Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 297: 883-887
5. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K (1992) Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester pregnancy. Br Med J 304: 867-869
6. Pandya PP, Snijders RJM, Johnson SP, Brizot M, Nicolaides KH (1995) Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynecol 102: 957-962
7. Zimmermann R, Huch A, Savoldelli G, Binkert F, Achermann J, Grudzinskas JG (1996) Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities. Br J Obstet Gynecol 103: 1009-1014
8. Orlandi F, Darmiani G, Hallahan TW, Krantz DA, Macri JN (1997) First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 10: 381-386
9. Blakemore (1998) Opinion: Nuchal translucency. Ultrasound Obstet Gynecol 11: 388-390
10. van Zalen-Sprock RM, Van Vugt JMG, van Geijn HP (1992) First-trimester diagnosis of cystic hygroma - course and outcome. Am J Obstet Gynecol 167: 94-98
11. Nadel A, Bromley B, Benacerraf BR (1993) Nuchal thickening of cystic hygromas in first-and early second-trimester fetuses: prognosis and outcome. Obstet Gynecol 82: 43-48
12. Johnson, MP, Johnson A, Hozgreve W et al. (1993) First-trimester simple hygroma: Cause and outcome. Am J Obstet Gynecol 168: 156-161
13. Trauffer PML, Anderson CE, Johnson A, Heeger S, Morgan P, Wapner RJ (1994) The natural history of euploid pregnancies with first-trimester cystic hygromas. Am J Obstet Gynecol 170: 1279-1284
14. Shulman LP, Emerson DS, Grevengood C, Felker RE, Gross SJ, Phillips OP, Elias S (1994) Clinical course and outcome of fetuses with isolataed nuchal lesions and normal karyotypes detected in the first trimester. Am J Obstet Gynecol 171: 1278-1281
15. Salvesen DR, Goble O (1995) Early amniocentesis and fetal nuchal translucency in women requesting karyotyping for advanced maternal age. Prenat Diagn 15: 971-974
16. Moselhi M, Thilaganathan B (1996) Nuchal translucency: a marker for the antenatal diagnosis of aortic coarctation. Br J Obstet Gynecol 103: 1044-1045
17. Cha'ban FK, Van Splunder P, Los FJ, Wladimiroff JW (1996) Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype. Prenat Diagn 16: 537-541
18. D'Ottavio G, Meir YJ, Rustico MA et al. (1997) Screening for fetal anomalies by ultrasound at 14 and 21 weeks. Ultrasound Obstet Gynecol 10: 375-380
19. Reynders CS, Pauker SP, Benacerraf BR (1997) First trimester isolated fetal nuchal translucency: significance and outcome. J Ultrasound Med 16: 101-105
20. Thilaganathan B, Slack A, Wathen NC (1997) Effect of first trimester nuchal translucency on second trimester maternal serum biochemical screening for Down's syndrome. Ultrasound Obstet Gynecol 10: 261-264
21. Hafner E, Schuchter K, Liebhart E, Philipp K (1998) Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women. Prenat Diagn 18: 29-34
22. van Vugt JMG, Tinnemans BWS, van Zalen-Sprock RM (1998) Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 11: 407-409
23. Bilardo CM, Paijkrt E, deGraaf J, Mol BW, Bleker OP (1998) Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 11: 401-406
24. Fukada Y, Yasumizu T, Takizawa M, Amemiya A, Hoshi K (1998) The prognosis of fetuses with transient nuchal translucency in the first and early second trimester. Acta Obstet Gynecol Scand 76: 913-916
25. Souka SP, Snijders RJM, Novakov A, Soares W, Nicolaides KH (1998) Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 11: 391-400
26. Pandya PP, Kondylios A, Hilbert L, Snijders RJM, Nicolaides KH (1995) Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 5: 115-119
27. Souka AP, Nicolaides KH (1997) Diagnosis of fetal abnormalities at the 10-14-week scan. Ultrasound Obstet Gynecol 10: 429-442
28. Benacerraf BR, Gelman R, Frigoletto FD (1987) Sonographic identification of second trimester fetuses with Down's syndrome. N Engl J Med 317: 1371-1376
29. Bronshtein M, Rottem S, Yoffe N, Blumenfeld Z (1989) First-trimester and early second trimester diagnosis of nuchal cystic hygroma by transvaginal sonography: Diverse prognosis of the septated from the nonseptatde lesion. Am J Obstet Gynecol 161: 78-82
30. Nicolaides KH, Azar G, Snijders RJ, Gosden CM (1992) Fetal nuchal oedema: associated malformations and chromosomal defects. Fetal Diagn Ther 7: 123-131
31. Azar GB, Snijders RJ, Gosden C, Nicolaides KH (1991) Fetal nuchal cystic hygromata: associated malformations and chromosomal defects. Fetal Diagn Ther 6: 46-57
32. Chervenak FA, Isaacson G, Blakemore KJ et al. (1983) Fetal cystic hygroma, cause and natural history. N Engl J Med 309: 822-825
33. Orlandi F, Damiani G, Hallahan TW, Krantz DA, Macri JN (1997) First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol 10: 381-386
34. Pandya PP, Altman DG, Brizot ML, Pettersen H, Nicolaides KH (1995) Repeatability of measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 5: 334-337
35. Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A (1998) Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med 338: 955-961
36. Whitlow BJ, Chatzipapas IK, Economides DL (1998) The effect of fetal neck position on nuchal translucency measurement. Br J Obstet Gynecol 105: 872-876
37. Roberts LJ, Bewley S, Mackinson AM, Rodeck CH (1995) First trimester fetal nuchal translucency: problems with screening the general population. Br J Obstet Gynecol 102: 381-385
38. Brambati B, Cislaghi C, Tului L, Alberti E, Amidani M, Colombo U, Zuliani G (1995) First trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling. Ultrasound Obstet Gynecol 5: 9-14
39. Braithwaite JM, Morris RW, Economides DL (1996) Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynecol 103: 1201-1204
40. Pajkrt E, de Graaf IM, Mol BW, van Lith JM, Bleker OP, Bilardo CM (1998) Weekly nuchal translucency measurements in normal fetuses. Obstet Gynecol 91: 208-211
41. Pandya PP, Snijders RJM, Johnson S, Nicolaides KH (1995) Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 5: 381-383
42. Reuss A, Pijpers L, Schampers PTFM, Wladimiroff JW, Sachs ES (1987) The importance of chorionic villus sampling after first trimester diagnosis of cystic hygroma. Prenat Diagn 7: 299-301
43. Taipale P, Hiilesmaa V, Salonen R, Ylöstalo P (1997) Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 337: 1654-1658
44. Hafner E, Schuchter K, Philipp K (1995) Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency. Ultrasound Obstet Gynecol 6: 330-333
45. Pajkrt E, van Lith MM, Mol BWJ, Bleker OP, Bilardo CM (1998) Screening for Down's syndrome by fetal nuchal translucency measurement in a general population. Ultrasound Obstet Gynecol 12: 163-169
46. Pajkrt E, van Lith MM, Mol BWJ, Bleker OP, Bilardo CM (1998) Screening for Down's syndrome by fetal nuchal translucency measurement in a high risk population. Ultrasound Obstet Gynecol 12: 156-163
47. 'Fetal database'. Software, Fetal medicine Foundation, 8 Devonshire Place, London W1N 1PB
48. Hyett JA, Sebire NJ, Nicolaides KH (1996) Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 7: 101-103
49. Hyett JA, Moscoso G, Nicolaides KH (1995) First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. Am J Obstet Gynecol 172: 1411-1413
50. Tubman TRJ, Shields MD, Craig BG, Mulholland HC, Nevin NC (1991) Congenital heart disease in Down's syndrome: two year prospective early screening study. Br Med J302: 1425-1427
51. Hyett JA, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH (1996) Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7: 245-250
52. Huisman TWA, Bilardo CM (1997) Transient increase in nuchal translucency thickness and reversed end-diastolic ductus venosus flow in a fetus with trisomy 18. Ultrasound Obstet Gynecol 10: 397-399
53. Montenegro N, Mafias A, Areias C, Castedo S, Barros H (1997) Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 10: 265-268
54. Hyett JA, Perdu M, Sharland GK, Snijders RSM, Nicolaides KH (1997) Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 10: 242-246
55. Gembruch U, Knopfle G, Bald R, Hansmann M (1993) Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 3: 310-317
56. Sebire NJ, Snijders RJM, Davenport M, Greenough A, Nicolaides KH (1997) Fetal nuchal translucency thickness at 10-14 weeks of gestation and congenital diaphragmatic hernia. Obstet Gynecol 90: 943-946
57. van Zalen-Sprock RM, Van Vugt JMG, van Geijn HP (1997) First-trimester sonography of physiological midgut herniation and early diagnosis of omphalocele. Prenatal Diagn 17: 511-518
58. Blaas H-G, Eik-Nes S, Kiserud T, Hellevik LR (1995) Early development of the abdominal wall, stomach and heart from 7 to 12 weeks of gestation: a longitudinal ultrasound study. Obstet Gynecol 6: 240-249
59. Mann L, Ferguson-Smith MA, Desai M, Gibson AAM, Raine PAM (1984) Prenatal assessment of anterior abdominal wall defects and their prognosis. Prenat Diagn 4: 427-435
60. Daskalakis G, Sebire NJ, Jurkovic D, Snijders RJM, Nicolaides KH (1997) Body stalk anomaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 10: 416-418
61. Smith DW (1982) Recognizable patterns of human malformation. Saunders, Philadelphia, p 228
62. Hyett J, Noble P, Sebire NJ, Snijders R, Nicolaides KH (1997) Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 9: 310-313
63. Ville Y, Lalondrelle C, Doumerc S, Daffos F, Frydman R, Oury JF, Dumez Y (1992) First-trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol 2: 314-316
64. Fisk NM, Vaughan J, Smith M, Wigglesworth J (1991) Transvaginal ultrasound recognition of nuchal oedema in the first-trimester diagnosis of achondrogenesis. J Clin Ultrasound 19: 586-590
65. Soothill PW, Vuthiwong C, Rees H (1993) Achondrogenesis type 2 diagnosed by transvaginal ultrasound at 12 weeks of gestation. Prenat Diagn 13: 523-528
66. Ben Ami M, Perlitz Y, Haddad S, Matilsky M (1997) Increased nuchal translucency is associated with asphyxiating thoracic dysplasia. Ultrasound Obstet Gynecol 10: 297-298
67. Bulas D, Saal H, Allen JF, Kapur S, Nies BM, Newman K (1992) Cystic hygroma and congenital diaphragmatic hernia: early prenatal sonographic evaluation of Fryn's syndrome. Prenat Diagn 12: 867-875
68. Hosli IM, Tercanli S, Rehder H, Holzgreve W (1997) Cystic hygroma as an early first-trimester ultrasound marker for recurrent Fryns' syndrome. Ultrasound Obstet Gynecol 10: 422-424
69. Eliyahu S, Weiner E, Lahav D, Shalev E (1997) Early sonographic diagnosis of Jarcho-Levin syndrome: a prospective screening program in one family. Ultrasound Obstet Gynecol 9: 314-318
70. Hobbins JC, Jones OW, Gottesfeld S, Persutte W (1994) Transvaginal sonography and transabdominal embryoscopy in the first trimester dignosis of Smith-Lemli-Opitz syndrome type 2. Am J Obstet Gynecol 10: 425-428
71. Hyett JY, Clayton PT, Moscoso G, Nicolaides KH (1995) Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 58: 374-376
72. Sharp P, Haant E, Fletcher JM, Khong TY Carey WF (1997) First-trimester diagnosis of Smith-Lemli-Opitz syndrome. Prenat Diagn 17: 355-361
73. Jauniaux E (1997) Diagnosis and management of early non-immune hydrops fetalis. Prenat Diagn 17: 1261-1268
74. Sebire NJ, Bianco D, Snijders RJ, Zuckerman M, Nicolaides KH (1997) Increased fetal nuchal translucency thickness at 10-14 weeks: is screening for maternal-fetal infection necessary? Br J Obstet Gynaecol 104: 212-215
75. Smulian JC, Egan JFX, Rodis JF (1998) Fetal hydrops in the first trimester associated with maternal parvovirus infection. J Clin Ultrasound 26: 314-316
76. Evans MI, Goldberg JD, Dommergues M et al. (1994) Efficacy of second-trimester selective termination for fetal abnormalities: international collaborative experience among the world's largest centrs. Am J Obstet Gynecol 171: 90-94
77. Sebire NJ, Snijders RJ, Hughes K, Sepulveda W, Nicolaides KH (1997) The hidden mortality of monochorionic twin pregnancies. Br J Obstet Gynaecol 104: 1203-1207
78. Sebire NJ, D'Ercole C, Hughes K, Carvalho M, Nicolaides KH (1997) Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol 10: 86-89
79. Ultrasound screening for fetal abnormalities - report of the RCOG working party. RCOG, London
80. Statham H, Solomou W (1998) Antenatal screening for Down's syndrome. Lancet 352: 1862